FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to urology. Maintenance therapy of an idiopathic overactive bladder in a subject is carried out. Effective amount of trospium chloride is introduced into the bladder continuously for at least 42 days. Subject has received a previous therapy of an overactive bladder. Trospium chloride is introduced by means of an intravesical administration device; the intravesical administration device contains trospium chloride in amount of 100 mg to 2000 mg.
EFFECT: invention makes it possible to reduce inconvenience associated with bladder symptoms in a subject.
14 cl, 15 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
DRUG DELIVERY SYSTEMS AND METHODS FOR TREATMENT OF BLADDER VOIDING DYSFUNCTION AND OTHER LOWER URINARY TRACT DISORDERS BY USING TROSPIUM | 2013 |
|
RU2670749C9 |
METHOD FOR TREATMENT OF CANCER OF LOWER PATHWAY UROTHELIUM | 2017 |
|
RU2764747C2 |
METHOD OF TREATING A PATIENT WITH IDIOPATHIC OVERACTIVE BLADDER AND URINARY INCONTINENCE (OPTIONS) | 2018 |
|
RU2809797C2 |
DEVICES AND METHODS FOR DRUG DELIVERY IN VIVO | 2018 |
|
RU2759868C2 |
METHODS OF TREATMENT OF TUMOR METASTASIS | 2018 |
|
RU2799546C2 |
INTEGRATED METHOD OF TREATING FEMALE PATIENTS SUFFERING FROM CHRONIC RECURRENT CYSTITIS AND REFRACTORY OVERACTIVE BLADDER | 2013 |
|
RU2550968C1 |
APPLIANCE OF SOLIFENACIN AND SALIVA FLOW STIMULATORS FOR THE TREATMENT OF OVERACTIVE BLADDER | 2012 |
|
RU2671575C2 |
METHOD FOR TREATMENT OF PAIN OR INTERSTITIAL CYSTITIS, USING INDOLE COMPOUND | 2019 |
|
RU2791025C2 |
SYSTEMS AND METHODS FOR DELIVERING DRUGS FOR TREATING BLADDER CANCER WITH GEMCITABINE | 2015 |
|
RU2694902C1 |
METHOD OF TREATING PATIENTS AGED 14-17 WITH ENURESIS | 2023 |
|
RU2820167C1 |
Authors
Dates
2024-12-19—Published
2019-07-31—Filed